Neurodermatitis clinical trials

Explore recruiting neurodermatitis clinical trials.

Recruiting neurodermatitis studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Neurodermatitis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, randomized, double-blind, placebo-controlled, parallel-group study to investigate the efficacy and safety of dupilumab for the treatment of pruritus of Lichen Simplex Chronicus (LSC) in adults

Greece, Germany, Spain, Italy, Hungary, Belgium +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, randomized, double-blind, placebo-controlled, parallel-group study to investigate the efficacy and safety of dupilumab for the treatment of pruritus of Lichen Simplex Chronicus (LSC) in adults

Hungary, Italy, Germany, Belgium, Greece, Czechia +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Neurodermatitis trials by city

Neurodermatitis in Toronto Neurodermatitis in Vancouver Neurodermatitis in Montreal Neurodermatitis in Calgary Neurodermatitis in Edmonton Neurodermatitis in Ottawa Neurodermatitis in Winnipeg Neurodermatitis in Quebec City Neurodermatitis in Hamilton Neurodermatitis in Kitchener Neurodermatitis in London Neurodermatitis in Halifax Neurodermatitis in New York Neurodermatitis in Los Angeles Neurodermatitis in Chicago Neurodermatitis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease